Totient - Part of Absci

Artificial Intelligence for Drug Discovery

Add To Watchlist
General Information
Company Name
Totient - Part of Absci
Founded Year
2017
Location (Offices)
Cambridge, United States +3
Founders / Decision Makers
Number of Employees
5
Industries
AI, Biotechnology, Life Sciences +1
Funding Stage
Series Unknown
Social Media

Totient - Part of Absci - Company Profile

Totient - Part of Absci

Slogan: Artificial Intelligence for Drug Discovery

Description: Totient is an AI-driven biotechnology company leveraging tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics. Beginning with a population of over 50,000 samples, they have reconstructed antibodies against known and novel extracellular oncology targets: GAGE1, GAGE2A, ANXA1, C4BPB, IL14A, BIRC7, HCLS1, GPR83, and others undisclosed.

Founded in: 2017

Industries: AI, Biotechnology, Life Sciences, Machine Learning

Headquarter: United States

Last Investment: Venture Round investment at 05 January 2021

Last Investment Investors: CerraCap Ventures, S16VC

Taxonomy: drug discovery, pharmaceuticals, medicines, biotech startups, bioinformatics, genomics, clinical trials, innovation, health sciences, precision medicine

Funding Rounds & Investors of Totient - Part of Absci (2)

View All
Funding Stage Amount No. Investors Investors Date
Venture Round Unknown 2
CerraCap Ventures, investor in Totient - Part of Absci's Venture Round round S16VC, investor in Totient - Part of Absci's Venture Round round
05 Jan 2021
Seed Round $10.00M 8
Kaitai Capital, investor in Totient - Part of Absci's Seed Round round Sands Capital Ventures, investor in Totient - Part of Absci's Seed Round round IKJ Capital, investor in Totient - Part of Absci's Seed Round round Das & Co., investor in Totient - Part of Absci's Seed Round round Tachyon Ventures, investor in Totient - Part of Absci's Seed Round round
Viva Biotech, Andrew Izyumov +1 		10 Sep 2020

Latest News of Totient - Part of Absci

View All

No recent news or press coverage available for Totient - Part of Absci.

Similar Companies to Totient - Part of Absci

View All
Trojan Bio - Similar company to Totient - Part of Absci
Trojan Bio Harnessing viral specific immunity for fighting cancer
Kling Biotherapeutics - Similar company to Totient - Part of Absci
Kling Biotherapeutics Amsterdam based biotech developing novel antibody based therapeutics
Abwiz Bio Inc - Similar company to Totient - Part of Absci
Abwiz Bio Inc Monoclonal antibody, antibody engineering, Phagedisplay
X-BODY Biosciences - Similar company to Totient - Part of Absci
X-BODY Biosciences
DAAN Biotherapeutics - Similar company to Totient - Part of Absci
DAAN Biotherapeutics Innovative treatments for cancer: empowering patients with advanced research in cell therapies, antibodies, and small molecule inhibitors.
Circle Decoration Circle Decoration

Want to dive deeper into Totient - Part of Absci? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now